Related references
Note: Only part of the references are listed.Human umbilical cord mesenchymal stem cell-derived exosomal miR-146a-5p reduces microglial-mediated neuroinflammation via suppression of the IRAK1/TRAF6 signaling pathway after ischemic stroke
Zhongfei Zhang et al.
Aging-US (2021)
Targeting USP47 overcomes tyrosine kinase inhibitor resistance and eradicates leukemia stem/progenitor cells in chronic myelogenous leukemia
Hu Lei et al.
NATURE COMMUNICATIONS (2021)
Glutamine Availability Controls BCR/Abl Protein Expression and Functional Phenotype of Chronic Myeloid Leukemia Cells Endowed with Stem/Progenitor Cell Potential
Martina Poteti et al.
CANCERS (2021)
De-regulated STAT5A/miR-202-5p/USP15/Caspase-6 regulatory axis suppresses CML cell apoptosis and contributes to Imatinib resistance
Zi-Yuan Nie et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
Chronic myeloid leukemia: 2020 update on diagnosis, therapy and monitoring
Elias Jabbour et al.
AMERICAN JOURNAL OF HEMATOLOGY (2020)
Exosomal microRNA-146a derived from mesenchymal stem cells increases the sensitivity of ovarian cancer cells to docetaxel and taxane via a LAMC2-mediated PI3K/Akt axis
Liya Qiu et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2020)
Metabolic Reprogramming of Chemoresistant Cancer Cells and the Potential Significance of Metabolic Regulation in the Reversal of Cancer Chemoresistance
Xun Chen et al.
METABOLITES (2020)
The Effect of Dysfunctional Ubiquitin Enzymes in the Pathogenesis of Most Common Diseases
Gizem Celebi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
The role of ubiquitination and deubiquitination in cancer metabolism
Tianshui Sun et al.
MOLECULAR CANCER (2020)
Trends in disease burden of chronic myeloid leukemia at the global, regional, and national levels: a population-based epidemiologic study
Liqing Ning et al.
EXPERIMENTAL HEMATOLOGY & ONCOLOGY (2020)
Glutaminase-1 (GLS1) inhibition limits metastatic progression in osteosarcoma
L. Ren et al.
CANCER & METABOLISM (2020)
BAG3 promotes autophagy and glutaminolysis via stabilizing glutaminase
Song Zhao et al.
CELL DEATH & DISEASE (2019)
Human Umbilical Cord Mesenchymal Stem Cell-Derived Extracellular Vesicles Inhibit Endometrial Cancer Cell Proliferation and Migration through Delivery of Exogenous miR-302a
Xin Li et al.
STEM CELLS INTERNATIONAL (2019)
USP10 modulates the SKP2/Bcr-Abl axis via stabilizing SKP2 in chronic myeloid leukemia
Yuning Liao et al.
CELL DISCOVERY (2019)
Lysosome Inhibition by Mefloquine Preferentially Enhances the Cytotoxic Effects of Tyrosine Kinase Inhibitors in Blast Phase Chronic Myeloid Leukemia
Hui Lam Yi et al.
TRANSLATIONAL ONCOLOGY (2019)
Glutamine Metabolism Drives Growth in Advanced Hormone Receptor Positive Breast Cancer
Diane M. Demas et al.
FRONTIERS IN ONCOLOGY (2019)
A view on drug resistance in cancer
Neil Vasan et al.
NATURE (2019)
Exosomes derived from human umbilical cord mesenchymal stem cells accelerate growth of VK2 vaginal epithelial cells through MicroRNAs in vitro
Zhongyi Zhu et al.
HUMAN REPRODUCTION (2019)
Exosomes from mesenchymal stem/stromal cells: a new therapeutic paradigm
Kan Yin et al.
BIOMARKER RESEARCH (2019)
Molecular targeting of glutaminase sensitizes ovarian cancer cells to chemotherapy
Chioniso P. Masamha et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2018)
Blockade of deubiquitinase USP7 overcomes bortezomib resistance by suppressing NF-kappa B signaling pathway in multiple myeloma
Yao Yao et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2018)
Glutaminase-1 stimulates the proliferation, migration, and survival of human endothelial cells
Kelly J. Peyton et al.
BIOCHEMICAL PHARMACOLOGY (2018)
USP6 Confers Sensitivity to IFN-Mediated Apoptosis through Modulation of TRAIL Signaling in Ewing Sarcoma
Ian C. Henrich et al.
MOLECULAR CANCER RESEARCH (2018)
Effect of exosomal miRNA on cancer biology and clinical applications
Zhenqiang Sun et al.
MOLECULAR CANCER (2018)
Current Opinions on Chemoresistance: An Overview
Saba Hasan et al.
BIOINFORMATION (2018)
Incidence of second primary malignancies and related mortality in patients with imatinib-treated chronic myeloid leukemia
Gabriele Gugliotta et al.
HAEMATOLOGICA (2017)
Treatment of chronic myeloid leukemia: assessing risk, monitoring response, and optimizing outcome
Naranie Shanmuganathan et al.
LEUKEMIA & LYMPHOMA (2017)
MicroRNAs that affect the Fanconi Anemia/BRCA pathway are downregulated in imatinib-resistant chronic myeloid leukemia patients without detectable BCR-ABL kinase domain mutations
E. Yap et al.
LEUKEMIA RESEARCH (2017)
Incidence of second primary malignancies and related mortality in patients with imatinib-treated chronic myeloid leukemia
Gabriele Gugliotta et al.
HAEMATOLOGICA (2017)
Glutamine Metabolism in Cancer: Understanding the Heterogeneity
Ahmad A. Cluntun et al.
TRENDS IN CANCER (2017)
The roles of microRNAs in the pathogenesis and drug resistance of chronic myelogenous leukemia
Carla Di Stefano et al.
ONCOLOGY REPORTS (2016)
Small Molecule Inhibition of the Ubiquitin-specific Protease USP2 Accelerates cyclin D1 Degradation and Leads to Cell Cycle Arrest in Colorectal Cancer and Mantle Cell Lymphoma Models
Mindy I. Davis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Reductive carboxylation supports redox homeostasis during anchorage-independent growth
Lei Jiang et al.
NATURE (2016)
Selenite inhibits glutamine metabolism and induces apoptosis by regulating GLS1 protein degradation via APC/C-CDH1 pathway in colorectal cancer cells
Junzhang Zhao et al.
Oncotarget (2016)
Differential and transferable modulatory effects of mesenchymal stromal cell-derived extracellular vesicles on T, B and NK cell functions
Mariano Di Trapani et al.
SCIENTIFIC REPORTS (2016)
From Krebs to clinic: glutamine metabolism to cancer therapy (vol 16, pg 619, 2016)
Brian J. Altman et al.
NATURE REVIEWS CANCER (2016)
Silencing of glutaminase 1 resensitizes Taxol-resistant breast cancer cells to Taxol
Aiqin Fu et al.
MOLECULAR MEDICINE REPORTS (2015)
Glutaminase Isoenzymes as Key Regulators in Metabolic and Oxidative Stress Against Cancer
J.M. Mates et al.
CURRENT MOLECULAR MEDICINE (2013)
Glutamine and cancer: cell biology, physiology, and clinical opportunities
Christopher T. Hensley et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Expression patterns of microRNAs associated with CML phases and their disease related targets
Katerina Machova Polakova et al.
MOLECULAR CANCER (2011)
Exosomes: immune properties and potential clinical implementations
Nathalie Chaput et al.
SEMINARS IN IMMUNOPATHOLOGY (2011)
Mesenchymal stem cell secretes microparticles enriched in pre-microRNAs
Tian Sheng Chen et al.
NUCLEIC ACIDS RESEARCH (2010)
MicroRNA Patterns Associated with Clinical Prognostic Parameters and CNS Relapse Prediction in Pediatric Acute Leukemia
Hua Zhang et al.
PLOS ONE (2009)
Chronic myelogenous leukemia: A review and update of therapeutic strategies
G Garcia-Manero et al.
CANCER (2003)
Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification
ME Gorre et al.
SCIENCE (2001)